News

STRATA Skin Sciences Announces Regaining Compliance with NASDAQ’S Minimum Price Rule

HORSHAM, Pa. , Feb. 27, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it had been notified by Nasdaq that

STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Inaugural Winter Clinical Conference

HORSHAM, Pa. , Feb. 16, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Joel L.

STRATA Skin Sciences Expects Record Full Year 2022 Revenue

Unaudited, preliminary revenue within the range of $35-$36 million Record revenue represents approximately 17-19% growth over full year 2021 HORSHAM, Pa. , Feb. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,

STRATA Skin Sciences Announces Poster Accepted at ODAC Dermatology, Aesthetic & Surgical Conference

All patients experienced a visible reduction in acne lesions HORSHAM, Pa. , Jan. 13, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic

STRATA Skin Sciences Expands into $300 Million Market with Exclusive Distribution Agreement in Mexico

HORSHAM, Pa. , Jan. 09, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced an exclusive agreement with MINO Labs , a